5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 Dapagliflozin Entèmedyè Faktori
Pwovizyon pou manifakti, segondè pite, pwodiksyon komèsyal
Dapagliflozin (CAS: 461432-26-8) Entèmedyè ki gen rapò:
5-Bromo-2-Chlorobenzoic Asid CAS 21739-92-4
5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilil-D-Gluconolactone CAS 32384-65-9
Non Chimik | 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane |
Sinonim | 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzèn;4-(5-Brom-2-Chlorbenzyl)phenyl-Ethylether;Dapagliflozin Bromo enpurite |
Nimewo CAS | 461432-23-5 |
Nimewo CAT | RF-PI447 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C15H14BrClO |
Pwa molekilè | 325,63 |
Pwen k ap fonn | 41.0 a 43.0 ℃ |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Blan a Pael jòn Crystalline Powder |
Pite / Metòd analiz | ≥99.0% (HPLC) |
Dlo (KF) | ≤0.50% |
Enpurte total | ≤1.0% |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Dapagliflozin (CAS: 461432-26-8), dyabèt tip II |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzèn (CAS: 461432-23-5) yo itilize kòm yon entèmedyè nan sentèz Dapagliflozin (CAS: 461432-26-8).Dapagliflozin se yon inibitè ki pisan, selektif ren sodyòm ki depann de glikoz kotranspòtè 2 (SGLT2) pou tretman dyabèt tip 2.Dapagliflozin se yon nouvo dwòg antidyabetik devlope ansanm pa Bristol-Myers Squibb ak AstraZeneca, ke Ajans Medikaman Ewopeyen an (EMA) te apwouve nan dat 12 novanm 2012. Nan dat 8 janvye 2014, US Food and Drug Administration (FDA) te apwouve li. pou itilize nan tretman dyabèt tip II.